Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
03/31/2004 | EP1401506A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
03/31/2004 | EP1401505A1 A population of hoxb8 mutants and uses in identifying agents for treating repetitive behaviors |
03/31/2004 | EP1401479A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
03/31/2004 | EP1401430A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis |
03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
03/31/2004 | EP1401267A1 Animal model for allergy |
03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
03/31/2004 | EP0783325B2 Contrast agent |
03/31/2004 | CN1486299A Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them |
03/31/2004 | CN1144048C Process for detecting analytes by measurement of residual magnetism and compound |
03/30/2004 | US6713046 Administering specified magnetic resonance imaging agent, exposing to light to cleave photocleavable moiety and increase exchange of water in at least one coordination site, producing image of cell, tissue or patient, eliciting therapeutic effect |
03/30/2004 | US6713045 Targeted magnetic resonance imaging agents for the detection of physiological processes |
03/30/2004 | US6712802 Metabolic therapy directed at electron transport |
03/30/2004 | CA2178602C Microcapsules, method of making and their use |
03/25/2004 | WO2004025270A2 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
03/25/2004 | WO2004025259A2 Site-specific labeling of affinity tags in fusion proteins |
03/25/2004 | WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
03/25/2004 | WO2004024883A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
03/25/2004 | WO2004024877A2 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
03/25/2004 | WO2004024192A1 Monitoring and diagnosis of gastric emptying and gastroparesis |
03/25/2004 | WO2004024191A2 Use of metallic particles to improve fluorescence imaging |
03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
03/25/2004 | WO2004016303A9 Threaded syringe with quick stop |
03/25/2004 | WO2004001409A3 Method for screening modulators of the transmission of immunity |
03/25/2004 | WO2003075747A3 Contrast agents for magnetic resonance imaging and methods related thereto |
03/25/2004 | WO2003074523A3 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
03/25/2004 | WO2003033680A3 Kinases and phosphatases |
03/25/2004 | WO2003028633A3 Parenteral delivery systems |
03/25/2004 | WO2003014121A9 Compounds, derivatives, compositions, preparation and uses |
03/25/2004 | WO2002055112A3 Polypodal chelants for metallopharmaceuticals |
03/25/2004 | US20040059393 Regulation of eating habits |
03/25/2004 | US20040058951 Integrin targeted imaging agents |
03/25/2004 | US20040058082 Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging |
03/25/2004 | US20040058010 Drugs, bio-affecting and body treating compositions |
03/25/2004 | US20040057991 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
03/25/2004 | US20040057946 Forming a solution of protein encapsulated, insoluble gas-filled microbubbles conjugated to biological agent; administering solution to animal; so that protein directs microbubble-conjugated agent to sites of bioprocessing |
03/25/2004 | US20040057940 Imaging and targeting tumors using sickle cells |
03/25/2004 | US20040057905 Nanoparticulate beclomethasone dipropionate compositions |
03/25/2004 | US20040057904 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
03/25/2004 | US20040057903 Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism |
03/25/2004 | US20040057900 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
03/25/2004 | CA2498583A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
03/25/2004 | CA2498507A1 Monitoring and diagnosis of gastric emptying and gastroparesis |
03/25/2004 | CA2498378A1 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
03/25/2004 | CA2497801A1 Paks as modifiers of the chk pathway and methods of use |
03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
03/24/2004 | EP1399187A2 Uses of monoclonal antibody 8h9 |
03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
03/24/2004 | EP1284654A4 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging |
03/24/2004 | EP1121456A4 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
03/24/2004 | EP0725633B1 Capsule for detecting Helicobacter Pylori in the stomach |
03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
03/23/2004 | US6709650 Spray-dried microparticles and their use as therapeutic vehicles |
03/23/2004 | US6709646 Bioactivated diagnostic imaging contrast agents |
03/18/2004 | WO2004023099A2 Nanoengineered biophotonic hybrid device |
03/18/2004 | WO2004022709A2 Epitope sequences |
03/18/2004 | WO2004011035A3 Bio-degradable microspheres for diagnosing gastroesophagal reflux |
03/18/2004 | WO2003086563A3 Diabetes imaging probes |
03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
03/18/2004 | WO2003017818A3 Management of gastro-intestinal disorders |
03/18/2004 | WO2003011618A8 Nonskid device for the wheels of vehicles |
03/18/2004 | US20040054178 Labels for chromatography, spectroscopes |
03/18/2004 | US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases |
03/18/2004 | US20040053911 Reacting a substituted bis- indole compound with a chelating agent |
03/18/2004 | US20040053823 Polypeptides with amino acid sequences or peptidomimetics |
03/18/2004 | US20040053241 Enzymatic amino acid sequences for preventing protein degradation; mimetic enzyme inhibitors and drug design; developing genetic vaccines |
03/18/2004 | US20040052731 Adjustment lipophilic of drug; prevent drug abuse; enteric coating |
03/18/2004 | US20040052728 Diagnostic imaging |
03/18/2004 | DE10242367A1 Thermolabile liposomes with good stability in serum, e.g. for release of drugs or contrast agents in hyperthermic areas around tumors, formed from phosphatidyl choline(s) and phosphatidyl oligoglycerol |
03/18/2004 | CA2496888A1 Epitope sequences |
03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
03/17/2004 | EP1397429A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
03/17/2004 | EP1397339A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
03/17/2004 | EP0866655B1 Murine model for human carcinoma |
03/17/2004 | CN1141978C Method for infecting mouse with pylorospirobacillus |
03/16/2004 | US6706947 Method for screening for agents against cancer using an immunosuppression animal model |
03/16/2004 | US6706280 Drug targeting with liposomes and magnetic resonance imaging contrast media for diagnostics |
03/16/2004 | US6706254 Cyanine dye bioconjugates useful for diagnostic imaging and therapy |
03/16/2004 | US6706253 Comprising perfluorocarbon gas osmotic agent, modifier gas, sucrose stearate surfactant; long-lived microbubbles for ultrasound contrast enhancement |
03/11/2004 | WO2004020011A1 Embolization |
03/11/2004 | WO2004019999A2 Agent delivery particle |
03/11/2004 | WO2004019998A1 Methods for functional kidney imaging using dendrimer conjugate contrast agents |
03/11/2004 | WO2004019997A1 Method and apparatus for producing contrast agents for magnetic resonance imaging |
03/11/2004 | WO2004019996A1 Method and arrangement for producing contrast agent for magnetic resonance imaging |
03/11/2004 | WO2004019995A2 Method and apparatus for producing contrast agents for magnetic resonance imaging |
03/11/2004 | WO2003074091A3 Near infrared fluorescent contrast agent and method for fluorescence imaging |
03/11/2004 | WO2003072125A8 Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides |
03/11/2004 | WO2003001218A3 Macromolecular imaging agents for liver imaging |
03/11/2004 | WO2002082462A3 Stabilization and terminal sterilization of phospholipid formulations |
03/11/2004 | WO2002075318A3 Neurofibrillary labels |
03/11/2004 | WO2002058538A3 Methods of imaging and targeting vasculature |
03/11/2004 | US20040048910 Method of treating osteoarthritis |
03/11/2004 | US20040048888 1,6-naphthyridineurea derivatives; treating excessive or undesirable angiogenesis and/or Tie2 receptor activity |
03/11/2004 | US20040047902 To deliver a biologically active substance to the epidermis |
03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
03/11/2004 | CA2496802A1 Methods for functional kidney imaging using dendrimer conjugate contrast agents |
03/11/2004 | CA2496612A1 Embolization |
03/10/2004 | CN1481371A Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethy-l,4,7,10-tetraazacyclododecane, prodn. and use thereof |